Help Center

PLGF (Placental Growth Factor) serves as a vital biomarker for assessing the risk of preeclampsia in pregnancy. Screening asymptomatic women using PLGF testing allows for early identification of high-risk cases, enabling proactive management and improved outcomes. 

High PLGF levels indicate a higher likelihood of developing preeclampsia, leading to closer monitoring and preventive measures such as low-dose aspirin. By integrating PLGF testing into prenatal care, healthcare providers can enhance risk assessment, reduce healthcare costs, and promote better maternal and neonatal health.